Respiratory Diseases

Reagents for serology testing Antigen & Antibody Detection Assays SARS-CoV-2 | Continued

MAb to SARS-CoV-2 Nucleocapsid Protein • Capture antibody MAb to SARS-CoV-2 Nucleocapsid Protein • Detection antibody MAb to SARS-CoV-2 Nucleocapsid Protein • Capture antibody MAb to SARS-CoV-2 Nucleocapsid Protein • Detection antibody

BN1066

BN1067

Paired MAbs for Sandwich ELISA & LF Antigen Detection Assays

BN1066

BN1068

SYNERGISTIC EFFECT OF CAT# 9551 & 9565 ENHANCES DETECTION OF SARS-CoV-2TRIMERIC SPIKE PROTEIN

MAb sandwich ELISAs were compared for their ability to detect recombinant SARS-CoV-2 across 4 serial dilutions (10 ng/mL – 0.3 ng/mL). One assay used Cat# 9550 as the capture and Cat# 9551 as the detection antibody a second assay used Cat# 9550 as the capture and Cat# 9565 as the detection antibody and a third assays used Cat#9550 as the capture and Cat#9551 and Cat#9565 together in a 1:1 ratio as the detection antibodies. Using Cat# 9551 and 9565 in combination creates a synergistic effect that results in an enhanced detection of SARS-CoV-2 Trimeric Spike protein across all concentrations.

Respiratory Diseases- Reagents for Assay Development